Bank of New York Mellon Corp - TETRALOGIC PHARMACEUTICALS C ownership

TETRALOGIC PHARMACEUTICALS C's ticker is TLOG and the CUSIP is 88165U109. A total of 31 filers reported holding TETRALOGIC PHARMACEUTICALS C in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of TETRALOGIC PHARMACEUTICALS C
ValueSharesWeighting
Q3 2016$2,000
-50.0%
12,292
-12.0%
0.00%
Q2 2016$4,000
-20.0%
13,968
-56.6%
0.00%
Q1 2016$5,000
-79.2%
32,196
+136.4%
0.00%
Q4 2015$24,000
-89.4%
13,618
-88.8%
0.00%
Q3 2015$226,000
+606.2%
121,683
+793.5%
0.00%
Q2 2015$32,000
-39.6%
13,618
+12.8%
0.00%
Q1 2015$53,000
+10.4%
12,068
+20.7%
0.00%
Q4 2014$48,000
-79.5%
10,000
-72.7%
0.00%
Q1 2014$234,000
-49.7%
36,604
-25.0%
0.00%
Q4 2013$465,00048,8070.00%
Other shareholders
TETRALOGIC PHARMACEUTICALS C shareholders Q1 2015
NameSharesValueWeighting ↓
Clarus Ventures, LLC 4,644,705$19,322,0007.71%
First Washington CORP 185,250$771,0000.44%
SPHERA FUNDS MANAGEMENT LTD. 194,200$808,0000.10%
KINGDON CAPITAL MANAGEMENT, L.L.C. 286,801$1,173,0000.05%
EMERALD ADVISERS, LLC 175,000$728,0000.04%
Pine River Capital Management L.P. 209,900$873,0000.01%
Alyeska Investment Group, L.P. 79,196$329,0000.01%
HighTower Advisors, LLC 66,514$277,0000.01%
Tower Research Capital LLC (TRC) 1,441$6,0000.00%
First Eagle Investment Management, LLC 114,456$476,0000.00%
View complete list of TETRALOGIC PHARMACEUTICALS C shareholders